Fortis Healthcare Limited has delineated the utilization of proceeds from its recent issuance of Non-Convertible Debentures (NCDs), raising ₹1,550 Cr through a private placement on December 19, 2024. As of December 31, 2024, ₹429.37 Cr has been utilized, with the remaining funds also deployed by January 17, 2025. There has been no deviation from the intended use of proceeds, which primarily involve the acquisition of equity shares in Agilus Diagnostics Limited and associated expenses. The audit committee confirmed adherence to the planned utilization of funds.